THE POSSIBILITY OF USING TUMOR NECROSIS FACTOR-THYMOSIN-α1 IN NEOADJUVANT CHEMOTHERAPY OF BREAST CANCER

THE POSSIBILITY OF USING TUMOR NECROSIS FACTOR-THYMOSIN-α1 IN NEOADJUVANT CHEMOTHERAPY OF BREAST CANCER

The article covers the results of clinical application of a domestic drug based on recombinant tumor necrosis factor-alphathymosin-alpha1 (TNF-T) combined with chemotherapy FAC and РА during neoadjuvant treatment of patients with breast cancer IIB-IIIB stage. In contrast to the standard subcutaneous...

Full description

Bibliographic Details
Main Authors:	L. YU. VLADIMIROVA, N. A. PODZOROVA, E. M. NEPOMNYASCHAYA, E. YU. ZLATNIK, I. A. NOVIKOVA, E. P. ULYANOVA
Format:	Article
Language:	Russian
Published:	Remedium Group LLC 2016-12-01
Series:	Медицинский совет
Subjects:	breast cancer recombinant hybrid protein of tumor necrosis factor-alpha-thymosin-alpha1 neoadjuvant chemotherapy peritumoral application angiogenesis
Online Access:	https://www.med-sovet.pro/jour/article/view/1403

Similar Items

Effects of Thymosin Alpha-1 on Radiation-induced Pneumonitis
by: Rong YU, et al.
Published: (2011-03-01)

THYMUS PEPTIDES (THYMULIN, THYMOSIN ALPHA 1 AND THYMOSIN BETA 4) INHIBITING EFFECTS ON THE INTRINSIC BLOOD COAGULATION PATHWAY IN RATS
by: Negrin Negrev, et al.
Published: (2017-08-01)

Thymosin alpha1 based immunomodulatory therapy for sepsis: a systematic review and meta-analysis
by: Congcong Li, et al.
Published: (2015-04-01)

A Reappraisal of Thymosin Alpha1 in Cancer Therapy
by: Claudio Costantini, et al.
Published: (2019-09-01)

Assessing the Percent of Necrosis after Neoadjuvant Chemotherapy with 24hr Infusional Cisplatin/3 Days Doxorubicin Intermittent with IfosfamideDoxorubicin for Osteosarcoma
by: Mozhgan Aalam Samimi, et al.
Published: (2014-03-01)

Efficacy of low-dose interferon α-1b combined with ribavirin and thymosin α1 versus standard treatment for chronic hepatitis C: a comparative study
by: SUN Jianmin
Published: (2015-01-01)

Efficacy of Thymosin Alpha 1 in the Treatment of COVID-19: A Multicenter Cohort Study
by: Jiao Liu, et al.
Published: (2021-08-01)

The clinical efficacy and adverse effects of Entecavir plus Thymosin alpha-1 combination therapy versus Entecavir Monotherapy in HBV-related cirrhosis: a systematic review and meta-analysis
by: Dan Peng, et al.
Published: (2020-10-01)

Effect of pegylated interferon α-2a combined with thymosin α1 on quality of life in patients with chronic hepatitis B
by: LU Jianguo
Published: (2013-12-01)

Thymosin Alpha-1 Has no Beneficial Effect on Restoring CD4+ and CD8+ T Lymphocyte Counts in COVID-19 Patients
by: Zhenyan Wang, et al.
Published: (2021-06-01)

Efficacy Evaluation of Thymosin Alpha 1 in Non-severe Patients With COVID-19: A Retrospective Cohort Study Based on Propensity Score Matching
by: ChenLu Huang, et al.
Published: (2021-04-01)

Immunoreactivity for thymosin beta 4 and thymosin beta 10 in the adult rat oro-gastro-intestinal tract
by: S. Nemolato, et al.
Published: (2013-05-01)

The Plasma Concentration of D-Dimer is Associated with Neoadjuvant-Chemotherapy Efficacy and the Prognosis in Osteosarcoma
by: Huang Y, et al.
Published: (2021-01-01)

Cardioprotection by Systemic Dosing of Thymosin Beta Four Following Ischemic Myocardial Injury
by: Gordon Teg Pipes
Published: (2013-11-01)

Serum levels of VEGF and MCSF in HER2+ / HER2- breast cancer patients with metronomic neoadjuvant chemotherapy
by: Roberto J. Arai, et al.
Published: (2018-06-01)

Neoadjuvant and Adjuvant Chemotherapy in Osteosarcoma (The Experience of HORC in the Shariati Hospital)
by: Alimoghadam K, et al.
Published: (2004-07-01)

Thymosin alpha-1 blocks the accumulation of myeloid suppressor cells in NSCLC by inhibiting VEGF production
by: Zhenzhen Yang, et al.
Published: (2020-11-01)

Effect of preoperative Xiaoaiping combined with TEC neoadjuvant chemotherapy on malignant biological behaviors of breast cancer cells
by: Qin Yang, et al.
Published: (2018-10-01)

Verifiable Hypotheses for Thymosin β4-Dependent and -Independent Angiogenic Induction of Trichinella spiralis-Triggered Nurse Cell Formation
by: Mee Sun Ock, et al.
Published: (2013-11-01)

TUMOR ANGIOGENESIS IN THE PERITUMOR AREA IN KIDNEY CANCER PATIENTS: CLINICAL ASPECTS
by: T. M. Cherdantseva, et al.
Published: (2014-07-01)

TUMOR ANGIOGENESIS IN THE PERITUMOR AREA IN KIDNEY CANCER PATIENTS: CLINICAL ASPECTS
by: T. M. Cherdantseva, et al.
Published: (2014-07-01)

Stereotactic body radiation therapy and thymosin alpha-1-induced anti-tumor effects in heavily pretreated, metastatic esophageal squamous cell carcinoma patients
by: Dexi Du, et al.
Published: (2018-08-01)

Neoadjuvant and Adjuvant Chemotherapy in Osteosarcoma (The Experience of HORC in the Shariati Hospital)
by: K Alimoghadam, et al.
Published: (2004-03-01)

Impact of various options of neoadjuvant chemotherapy on the hormonal status of patients with breast cancer
by: Yu. S. Sidorenko, et al.
Published: (2014-08-01)

Deer thymosin beta 10 functions as a novel factor for angiogenesis and chondrogenesis during antler growth and regeneration
by: Wei Zhang, et al.
Published: (2018-06-01)

Neoadjuvant chemotherapy in neonatal Wilms′ tumor
by: Ramesh K Reddy, et al.
Published: (2015-01-01)

Thymosin beta 4 and thymosin beta 10 expression in hepatocellular carcinoma
by: W. Theunissen, et al.
Published: (2014-03-01)

Immunoreactivity of thymosin beta 4 in human foetal and adult genitourinary tract
by: S. Nemolato, et al.
Published: (2010-10-01)

Optimal Timing of Surgery after Neoadjuvant Chemotherapy of Breast Cancer
by: Borna Farazmand, et al.
Published: (2017-03-01)

Neoadjuvant chemotherapy for primary sarcoma of the breast: a case report
by: Chieko Miyazaki, et al.
Published: (2019-09-01)

Effect of neoadjuvant chemotherapy on malignant molecule levels in tumor tissue and serum of patients with locally advanced resectable colorectal cancer
by: Bin Huang
Published: (2016-10-01)

Expression pattern of thymosin beta 4 in the adult human liver
by: S. Nemolato, et al.
Published: (2011-09-01)

THYMOSIN β4 AS BASIS FOR CREATION OF A REPARATION PREPARATION OF NEW GENERATION
by: Mikhail Martynov, et al.
Published: (2016-09-01)

Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
by: Huaqin Lin, et al.
Published: (2021-05-01)

Neoadjuvant or adjuvant chemotherapy: what is the best treatment of muscle invasive bladder cancer?
by: Nabil Ismaili, et al.
Published: (2011-09-01)

NEOADJUVANT CHEMOTHERAPY WITH RADICAL CYSTECTOMY IN THE TREATMENT OF MUSCLE-INVASIVE BLADDER CANCER
by: N. S. Nurgaliev, et al.
Published: (2016-10-01)

Neoadjuvant Chemotherapy in Esophageal Cancer: Single Institution Experience
by: Shaffi Shaikh, et al.
Published: (2011-10-01)

Neoadjuvant Chemotherapy in Nasopharyngeal Carcinoma
by: Khudair J. Sabeeh Al-Rawaq
Published: (2012-04-01)

The main markers of the long-term efficiency of neoadjuvant chemotherapy in breast cancer (review of literature)
by: V F Semiglazov, et al.
Published: (2013-12-01)

Outcomes of neoadjuvant chemotherapy in resectable, borderline resectable and locally advanced pancreatic cancer
by: Kamil D. Dalgatov, et al.
Published: (2021-08-01)

Cannot write session to /tmp/vufind_sessions/sess_dckmsiigjdjpob2pa3ls0t46ut